HDFA treatment targets the blockage in the transportation of folate into the brain through the folate receptor alpha caused by blocking or binding autoantibodies (Frye et al., Overall, this study provides some insight to the potential benefits of safe and well-tolerated therapies that target specific metabolism abnormalities associated with ASD
While oral DFP has a risk of hematological toxicity (Ruivard and Lobbes, 2023), oral DFX can cause hepatic and renal toxicity and gastrointestinal bleeding with chronic use (Yusuf et al., 2023)
Its time to switch to a solution that goes deep into the skin and tackles melanin at its source
The good news is that Wegovys gastrointestinal side effects typically improve over time
Radwan SM, Abdel-Latif GA, Abbas SS, Elmongy NF, Wasfey EF
The FDA has approved several GLP-1 receptor agonists, including semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda)